Skip to main content

Table 2 Colonic mucosal gene expression among different groups

From: Gene expression analysis in NSAID-induced rat small intestinal disease model with the intervention of berberine by the liquid chip technology

 

Control group

Model group

Intervention group

HTR4

0.073 ± 0.030

0.383 ± 0.212a

0.228 ± 0.074b

HTR1a

0.137 ± 0.055

0.608 ± 0.252a

0.534 ± 0.353

F2RL3

0.294 ± 0.091

1.523 ± 0.502a

0.990 ± 0.295b

NOS1

1.254 ± 0.340

0.649 ± 0.289a

1.127 ± 0.315b

CALCA

0.271 ± 0.123

0.586 ± 0.314a

0.578 ± 0.319

NPY

0.243 ± 0.083

1.126 ± 0.354a

0.634 ± 0.262b

CRHR2

0.201 ± 0.078

0.836 ± 0.333a

0.538 ± 0.334b

IL1b

0.006 ± 0.001

0.082 ± 0.060a

0.044 ± 0.010b

P2RX3

0.147 ± 0.059

0.415 ± 0.272a

0.366 ± 0.179

NOS2

0.224 ± 0.072

0.517 ± 0.365

0.778 ± 0.443

TPH1

0.033 ± 0.012

0.275 ± 0.231a

0.299 ± 0.010

CRHR1

0.005 ± 0.002

0.028 ± 0.033

0.006 ± 0.002

HMOX1

0.495 ± 0.127

1.616 ± 0.624a

1.727 ± 0.449

TRPV1

0.053 ± 0.017

0.156 ± 0.087a

0.179 ± 0.109

VIP

0.594 ± 0.185

1.110 ± 0.406a

0.438 ± 0.167b

F2RL1

0.312 ± 0.047

1.451 ± 0.372a

1.483 ± 0.460

TGFB1

0.210 ± 0.050

0.205 ± 0.099

0.188 ± 0.050

HTR3a

0.204 ± 0.059

0.162 ± 0.081

0.136 ± 0.062

SLC6a4

0.249 ± 0.086

1.565 ± 0.553a

1.416 ± 0.540

TFF2

0.031 ± 0.011

0.114 ± 0.067a

0.140 ± 0.088

AQP8

0.227 ± 0.109

0.856 ± 0.253a

0.414 ± 0.201b

  1. a P < 0.05 compared with control group; b P < 0.05 compared with model group